INSTRUCTION FOR PREPARATION OF MANUSCRIPTS
PEDIATRIC ENDOCRINOLOGY REVIEWS (PER) publishes scholarly review articles in all areas of clinical and experimental Endocrinology, Diabetes, Nutrition and Metabolism. PER is intended for practicing pediatricians, pediatric endocrinologists, pediatric diabetologists, pediatric gastroenterologists, neonatologists, pediatric gynecologists, nutritionists, sport physicians and pediatricians-in-training.
PER will also publish topics on specific subjects or as proceedings of scientific meetings in the above fields of interest. All articles, whether invited or direct contributions, are peer-reviewed. PER publishes correspondence, book reviews, a meeting calendar and meeting reports.
Submit manuscripts online to email:
PER, Y.S. Medical Media Ltd., 8 Hamelacha St., Kiryat-Nordau Industrial Area, POB 8214, Netanya 42504, Israel.
If not possible send a hard copy (high-quality original plus 2 copies) to: Zvi Laron, MD, Editor-in-Chief, Endocrinology and Diabetes Research Unit, Schneider Children’s Medical Center, 14 Kaplan Street, Petah Tikva 49202, Israel. Tel: 972-3-9253610/1; Fax: 972-3-9253508; E-mail:
We prefer that all manuscripts be sent to us via email.
Must be typewritten in English in Arial 12 font on one side 8 1⁄2 x 11 inch (22 x 28 cm) heavy-duty white bond paper sequentially numbered, (including references, tables legends and footnotes). Abstract, references, tables and legends should each begin on a new page. Manuscripts should not exceed 16 printed pages including references, tables and figures. (4300 characters with spaces/page)
All accepted manuscripts are subject to editing. Meeting Report Same rules as for manuscripts Transfer of Author Copyright
Copyright release should be addressed to Y.S. Medical Media, Ltd., which should include the article title, date and must be signed by all the authors.
Include: authors’ names, academic degrees and departmental and institutional affiliations of each. Designate one author as the corresponding author and provide address: business and phone; telephone numbers, fax numbers and email.
Include a running title and up to 8 keywords.
Not exceeding 150 words, should incorporate data on background, Objective or hypothesis and main data. The abstracts will be available on the web. References
Should be cited consecutively in the text in parentheses, regular size, and listed in the same numerical order at the end of the paper. List the names of all authors. Reference Example
Woods KA, Camach-Hubner C, Savage MO, Clark AJL. Intrauterine growth retardation and postnatal deletion of the Insulin- like growth factor I gene. N Engl J Med 1996;335:1363-1367 Book Ghigo E, Boghen M, Casanueva FF, Dieguez C. Growth Hormone Secretagogues. Basic Findings and Clinical Implications. Amsterdam: Elsevier, 1994, 325 Chapter in book: Hofman PL, Pescovitz OH. Growth hormone releasing hormone - biological and molecular aspects. In: Handwerger S, ed. Molecular and Cellular Pediatric Endocrinology. Totowa, NJ: Humana Press, 1995;85- 112 Personal communications should not be included in the Reference list, but may be cited in the text in parentheses. Papers accepted and in press may be listed mentioning the journal.
Figures should be numbered consecutively. Legends of the figures should be typed single spaced on a separate sheet next to the word “legend”. The cost of color illustrations will be charged to the author if printed in the text.
Each table must be typed on a separate sheet and numbered consecutively. Large Tables will be treated as Figures and must be of acceptable quality for printing.
A reprint order form will be provided with the Galley Proofs. Galley Proofs After submission of all authors’ final corrections, only printer’s errors may be corrected.
Enquiries, Subscriptions, Reprints Enquiries concerning manuscripts in press, reprints or submission maybe addressed to:
PER Technical Editor, Y.S. Medical Media Ltd., 8 Hamelacha St., Kiryat-Nordau Industrial Area, POB 8214, Netanya 42504, Israel. Email:
Fax: 972-9-865- 6965
All editorial correspondence, including Supplements, should be addressed to the Editor-in-Chief.
Advertising by commercial firms should be addressed to PER Technical Editor, email: firstname.lastname@example.org. Web
Information includes manuscript instructions, content and abstracts.
PubMed requires all authors include a “conflict of interest statement” preceding the Reference section.